Self-directed therapy without appropriate medical supervision may result in adverse outcomes and is strongly discouraged
Gastrointestinal side effects, including changes in bowel frequency, are most pronounced during the initial weeks of treatment and following dose increases
For instance, other GLP-1 receptor agonists and medications affecting the central nervous system or blood pressure may also lead to dizziness
While mild side effects are expected with tirzepatide dosing for weight loss in units, certain symptoms require immediate medical attention
The label should clearly state: drug name (semaglutide or tirzepatide), concentration (mg/mL), total volume (mL), any additives (such as B12 or niacinamide), lot number, expiration date, and the compounding pharmacy name
Contact The Gillian Institute today at (317) 913-3260 for your virtual consultation or in-person visit, and let semaglutide help you unlock your bodys full potential.